ITOS
Ticker
iTeos Therapeutics, Inc.
ITOSiTeos Therapeutics, Inc. (ITOS) has 7 disclosed filings on Paydirt over the past 24 months from 6 corporate insiders: 1 purchase and 6 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Jun 10 2025 and filed Jun 11 2025. The most active filer was Michel Detheux with 2 filings. Data as of Nov 7 2026.
Add to watchlistFilings, 24m
7
1 buy · 6 sells
Traders, 24m
6
6 insiders
Volume, 24miDollar value disclosed in the window
$60.5M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Jun 10 2025
Filed Jun 11 2025
ADViAverage daily dollar volume
–
not on file
No price series on file for ITOS yet.
Volume by month
Buys $38.7M
Sells $21.9M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed · past 24 months
MD
Michel Detheux
Chief Executive Officer
2 filings · 0 buys, 2 sales
EL
EcoR1 Capital, LLC
Director
1 filing · 1 buy, 0 sales
DHRecent filings
Michel DetheuxSALE
Chief Executive Officer
$880K87,765 sh across 2 lots
Exec Jun 9 2025
Filed Jun 11 2025 · 5:30 PM ET David HallalSALE Director $1.2M
114,682 sh across 3 lots
Exec Jun 4 2025
Filed Jun 6 2025 · 5:30 PM ET Michel DetheuxSALE Chief Executive Officer $1.3M
131,647 sh across 3 lots
Exec Jun 4 2025
Filed Jun 6 2025 · 5:30 PM ET EcoR1 Capital, LLCPURCHASE 10% owner $38.7M
4,958,978 sh across 2 lots
Exec May 14 2025
Filed May 16 2025 · 5:30 PM ET Mpm Bioventures 2018 (b), L.P.SALE Other $5.1M
630,191 sh × $8.06
Exec May 13 2025
Filed May 15 2025 · 5:30 PM ET MPM BioVentures 2018 GP LLCSALE Other $5.1M
630,191 sh × $8.06
Exec May 13 2025
Filed May 15 2025 · 5:30 PM ET MPM BioImpact LLCSALE Other $8.3M
1,031,931 sh × $8.06
Exec May 13 2025
Filed May 15 2025 · 5:30 PM ET